Review article · 2026

The expansion of kinase drug discovery: new targets, platforms and indications

Aleksandr V. Sokolov, Doriano Fabbro, Stefan Knapp, Helgi B. Schiöth

Nature Reviews Drug Discovery · Published 11 November 2026 · DOI 10.1038/s41573-026-01551-y

View at the publisherCite this paper

In brief

“The expansion of kinase drug discovery: new targets, platforms and indications” is a 2026 review article by Aleksandr V. Sokolov and 3 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
330
Authors
4

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sokolov, A. V., Fabbro, D., Knapp, S., & Schiöth, H. B. (2026). The expansion of kinase drug discovery: new targets, platforms and indications. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01551-y

MLA 9

Sokolov, Aleksandr V., et al. “The expansion of kinase drug discovery: new targets, platforms and indications.” Nature Reviews Drug Discovery, 2026. https://doi.org/10.1038/s41573-026-01551-y.

Chicago

Sokolov, Aleksandr V., Doriano Fabbro, Stefan Knapp, and Helgi B. Schiöth. 2026. “The expansion of kinase drug discovery: new targets, platforms and indications.” Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01551-y.

Harvard

Sokolov, A. V. et al. (2026) ‘The expansion of kinase drug discovery: new targets, platforms and indications’, Nature Reviews Drug Discovery. doi:10.1038/s41573-026-01551-y.

IEEE

A. V. Sokolov, D. Fabbro, S. Knapp, and H. B. Schiöth, “The expansion of kinase drug discovery: new targets, platforms and indications,” Nature Reviews Drug Discovery, 2026, doi: 10.1038/s41573-026-01551-y.

BibTeX

@article{sokolov2026expansion,
  title     = {{The expansion of kinase drug discovery: new targets, platforms and indications}},
  author    = {Sokolov, Aleksandr V. and Fabbro, Doriano and Knapp, Stefan and Schiöth, Helgi B.},
  journal   = {Nature Reviews Drug Discovery},
  year      = {2026},
  doi       = {10.1038/s41573-026-01551-y},
  url       = {https://doi.org/10.1038/s41573-026-01551-y}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • kinase drug discovery
  • protein kinases
  • allosteric inhibitors
  • covalent inhibitors
  • kinase activators
  • targeted protein degraders
  • clinical trials
  • drug approval

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Sokolov, A. V., Fabbro, D., Knapp, S., & Schiöth, H. B. (2026). The expansion of kinase drug discovery: new targets, platforms and indications. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01551-y

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Aleksandr V. Sokolov, Doriano Fabbro, Stefan Knapp, Helgi B. Schiöth.

What is the DOI of this paper?

10.1038/s41573-026-01551-y, permanently at https://doi.org/10.1038/s41573-026-01551-y. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.